SCHEMBL875141

SCHEMBL875141

CCC(SCCCl)SCCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377277 0.78 TSHR (0.30)
SCHEMBL376837 0.74 TSHR (0.39)
SCHEMBL3378242 0.71
SCHEMBL11026448 0.69
SCHEMBL875827 0.69 MEN1 (0.30)
SCHEMBL15268533 0.67
SCHEMBL5168079 0.65 TDP1 (0.30)
SCHEMBL377255 0.63 MAPK1 (0.35)
SCHEMBL432441 0.63
SCHEMBL15798403 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2009507999-A 2009-02-26 JP claimed
EP-1926682-A2 SIGNAL ACTIVATED DECONTAMINATING COATING Crosslink Polymer Research (US) 2008-06-04 EP claimed
WO-2008018856-A2 SIGNAL ACTIVATED DECONTAMINATING COATING CROSSLINK POLYMER RESEARCH (US) 2008-02-14 WO claimed
WO-2002002192-A1 FORMULATIONS FOR NEUTRALIZATION OF CHEMICAL AND BIOLOGICAL TOXANTS SANDIA CORPORATION (US) 2002-01-10 WO claimed
EP-3860449-A1 ELECTRODE ARRANGEMENT Wearoptimo Pty Ltd (AU) 2021-08-11 EP disclosed
US-20210107942-A1 TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE ARAIM PHARMACEUTICALS INC (US) 2021-04-15 US disclosed
US-10864253-B2 Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage ARAIM PHARMACEUTICALS, INC. (US) 2020-12-15 US disclosed
US-20200360476-A1 TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE ARAIM PHARMACEUTICALS, INC. 2020-11-19 US disclosed
CN-111346213-A Tissue protective peptides and peptide analogs for the prevention and treatment of diseases and disorders associated with tissue damage 阿拉伊姆药品公司 2020-06-30 CN disclosed
WO-2020069570-A1 ANALYTE DETECTION SYSTEM WearOptimo Pty Ltd (AU) 2020-04-09 WO disclosed
WO-2020069568-A1 TREATMENT DELIVERY SYSTEM WearOptimo Pty Ltd (AU) 2020-04-09 WO disclosed
WO-2020069567-A1 ELECTRODE ARRANGEMENT WearOptimo Pty Ltd (AU) 2020-04-09 WO disclosed
WO-2009094172-A2 TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE ARAIM PHARMACEUTICALS, INC. (US) 2009-07-30 WO disclosed
WO-2009023731-A1 COMPOSITIONS FOR NEUTRALIZATION AND DECONTAMINATION OF TOXIC CHEMICAL AND BIOLOGICAL AGENTS SUNREZ CORPORATION (US) 2009-02-19 WO disclosed
WO-2008121896-A2 METHODS FOR CLASSIFICATION OF TOXIC AGENTS AND COUNTERAGENTS BIOSEEK, INC. (US) 2008-10-09 WO disclosed
EP-1926682-A2 SIGNAL ACTIVATED DECONTAMINATING COATING Crosslink Polymer Research (US) 2008-06-04 EP disclosed
WO-2008018856-A2 SIGNAL ACTIVATED DECONTAMINATING COATING CROSSLINK POLYMER RESEARCH (US) 2008-02-14 WO disclosed
EP-1560486-A2 DECONTAMINATING SYSTEMS CONTAINING REACTIVE NANOPARTICLES AND BIOCIDES Nanoscale Materials, Inc. (US) 2005-08-10 EP disclosed
WO-2004032624-A2 DECONTAMINATING SYSTEMS CONTAINING REACTIVE NANOPARTICLES AND BIOCIDES NANOSCALE MATERIALS, INC. (US) 2004-04-22 WO disclosed
WO-2002002192-A1 FORMULATIONS FOR NEUTRALIZATION OF CHEMICAL AND BIOLOGICAL TOXANTS SANDIA CORPORATION (US) 2002-01-10 WO disclosed